Detalhe da pesquisa
1.
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial.
Brain Behav Immun
; 99: 147-156, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624483
2.
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial.
Brain Behav Immun
; 103: 50-60, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35341915
3.
The association between migrant status and transition in an ultra-high risk for psychosis population.
Soc Psychiatry Psychiatr Epidemiol
; 56(6): 943-952, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33399885
4.
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
BMC Med
; 18(1): 16, 2020 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948461
5.
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
Psychother Psychosom
; 86(5): 292-299, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903120
6.
Novel biotherapies are needed in youth mental health.
Australas Psychiatry
; 25(2): 117-120, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28375061
7.
White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.
BMC Psychiatry
; 16(1): 287, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515430
8.
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
BMC Psychiatry
; 16(1): 326, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650124
9.
Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis.
Aust N Z J Psychiatry
; 50(1): 56-63, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25690743
10.
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study.
Schizophr Bull
; 50(3): 579-588, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243809
11.
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial.
BJPsych Open
; 8(5): e165, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073014
12.
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
Transl Psychiatry
; 12(1): 454, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307392
13.
Greater preference for eveningness is associated with negative symptoms in an ultra-high risk for psychosis sample.
Early Interv Psychiatry
; 15(6): 1793-1798, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538110
14.
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis.
Early Interv Psychiatry
; 15(4): 874-881, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893462
15.
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
Front Psychiatry
; 11: 514, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32595533
16.
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
Biol Psychiatry
; 87(3): 243-252, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690495
17.
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
Schizophr Res
; 218: 48-54, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171637
18.
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Schizophr Res
; 226: 44-51, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301881
19.
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Schizophr Res
; 226: 52-60, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606244
20.
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial.
Behav Res Ther
; 124: 103527, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31790853